L&G Pharma Breakthrough UCITS ETF
ETLI.DE
#3284
ETF rank
C$39.93 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
C$20.22
Share price
-1.37%
Change (1 day)
10.73%
Change (1 year)

Expense ratio and fees for L&G Pharma Breakthrough UCITS ETF (ETLI.DE)

Total Expense Ratio

Total Expense Ratio as of November 2025: 0.49%

ter

ter as of October 2026: 0.49%